SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (981)4/16/2001 10:17:30 AM
From: aknahow  Read Replies (1) | Respond to of 3158
 
Any thoughts on the implications for DNA? Or are there none?

Besides being told that Roche is potentially looking at DNA type agreements, mergers and marketing agreements are we also being told Roche is for sale? The announcement left me confused.



To: Spekulatius who wrote (981)4/16/2001 3:11:17 PM
From: tommysdad  Read Replies (1) | Respond to of 3158
 
DuPont is looking to unload its Pharma business -- that's kind of old news. DuPont Pharma is probably the only company currently in play that fits the bill. Roche would be foolish not to be looking at buying DuPont Pharma.

Another potential suitor is Novartis.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News